Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • chenyao
    Member
    • Jul 2011
    • 74

    #1

    Any thing wrong with my cufflink process?

    Recently, I run cufflink in galaxy on the internet. I want to compare two samples, However, I found no transcript or gene passed the significant level, even many of them have large FPKM in one sample and 0 FPKM in another sample.

    Any thoughts?

    Below is my cufflink process:

    I have four samples belong to two group. the test have three samples, and the control has one sample.

    First, using accept_hit.bam from tophat, I run cufflink without annotation on each sample.

    Then, for the four "gtf" files from four samples, I run cuffcompare to combine these transcript and compare to the annotation genome. However, at this step, I found the transcript accuracy is very low.
    See one example:
    Missed exons: 10673/11776 ( 90.6%)
    Wrong exons: 1254/2007 ( 62.5%)
    Missed introns: 8529/8637 ( 98.7%)
    Wrong introns: 2/5 ( 40.0%)
    Missed loci: 0/504 ( 0.0%)
    Wrong loci: 1248/2002 ( 62.3%)

    at last, I run cufdiff between this two group sample.

    Thank you.
  • chenyao
    Member
    • Jul 2011
    • 74

    #2
    Any thoughts?

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Yesterday, 11:13 AM
    0 responses
    16 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, Yesterday, 10:48 AM
    0 responses
    16 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    35 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    42 views
    0 reactions
    Last Post SEQadmin2  
    Working...